The abstract is read at the publisher; the summary is JClub's.
Sex chromosome aneuploidies (SCAs) are collectively common (~1/400 individuals) and show high penetrance across multiple neuropsychiatric outcomes, often exceeding better recognized genetic risk factors.
- Why it matters: The field needs integration across epidemiology, behavior, neuroimaging, and genomics because SCAs’ symptom burden and diagnostic penetrance are underappreciated, including effects below diagnostic thresholds.
- What they did: This integrative review synthesizes the latest epidemiological, behavioral, neuroimaging, and genomic studies, highlighting differential sensitivity to X- versus Y-chromosome changes and large brain-size and regional-anatomy effects linked to X- and Y-dosage.
- The result: The reviewed evidence supports SCAs as impactful genetic disorders and genetics-first models for psychiatry, and it points to dosage-sensitive X-Y gametologs that may shape autosomal gene expression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.